According to a market report, published by Sheer Analytics and Insights, The global nebulizer market was valued at $1.1 billion in 2021 and it is expected to reach $2.4 billion at a CAGR of 7.3% between 2022 and 2032. With the significant increase in the world's geriatric population, more equipment and devices are being used to address the many problems facing the aging population. Additionally, the usage of several cutting-edge gadgets for the treatment of a wide variety of diseases has been prompted by the rising per capita income of customers in both developed and developing nations. Nebulizer device manufacturers anticipate a change in pricing as production moves to developing nations. Moreover, smoking, pollution, and changing lifestyles are just a few of the factors contributing to an increase in respiratory issues. Businesses are likely to accelerate product development to get a competitive edge in the worldwide nebulizers market. On the other side, it is projected that during the forecast period, drug delivery loss will restrain the growth of the worldwide nebulizers market. These major factors are anticipated to drive the nebulizer market globally during the forecast period.
The prevalence of chronic respiratory disorders is on the rise, which is a key factor driving the market's expansion. Obesity prevalence has increased globally as a result of busy schedules, sedentary lifestyles, and a lack of physical activity. The ease and inexpensive availability of land in poor countries can be blamed for the shifting manufacture of nebulizer devices. Many other businesses are eager to establish manufacturing facilities in emerging nations. Additionally, it is anticipated that technical developments such as drug-device combos may open up novel business prospects. On the other hand, the primary factor impeding market expansion is medication loss during nebulization. Therefore, these rising factors would accelerate the market growth and are also expected to create more growth opportunities in the future
Request a free PDF sample report: https://www.sheeranalyticsandinsights.com/request-sample/nebulizer-market-21
Global market expansion is being driven by the rising awareness of respiratory disorders and the widespread availability of nebulizers. Nebulizer sales are anticipated to rise as a result of the expanding availability of retail pharmacies and online pharmacies on international markets. Additionally, it is anticipated that increasing investments by the leading market players in the research and development of several new nebulizers with cutting-edge features will boost sales of nebulizers. Furthermore, the launch of new products by a number of the industry's main companies is fueling the market's expansion. Additionally, regulatory bodies like the FDA and EMA are essential in the approval of new product releases by market players. Hence, these would gain a more significant share of the global nebulizer market.
The competitive landscape section focuses on the major growth strategies of the key market players for nebulizers worldwide. In-depth segment analysis aids in the comprehension of market dynamics and aids in decision-making for market experts. However, several restraints are expected to hamper the market in the upcoming years. For instance, a device that rapidly and repeatedly delivers enough medicine to the site of action while minimizing waste is needed for nebulizer therapy. Smaller aerosol particles are supplied to the site of action or inhaled during nebulization, whereas larger particles return to the reservoir feeding tube. Additionally, some of the drug aerosols land on the baffle's walls. Drug waste is the result of this. The market for nebulizers is consequently facing a challenge from drug waste during exhalation.
Some new developments in the global nebulizer market:
- In 2020, OMRON introduced a nebulizer that is affordable and suitable for all age groups. With a nebulizer, a patient can combine several treatments as directed by the doctor, and both upper and lower airways can be treated with only one machine.
- In 2021, Cipla started a project to increase access to nebulizers for treating acute asthma in basic healthcare facilities in rural India. Cipla is also seeking to set a World Record by producing the "biggest nebulizer sentence" with these 5,000 nebulizers in an effort to address the low awareness surrounding the use of nebulization in the therapy of acute diseases.
According to the study, key players dominating the global nebulizer market are Allied Healthcare Products (U.S), Agilent Technologies (U.S), Aerogen Limited (Ireland), Briggs Medical Service (U.S), BD (U.S), Beurer (Germany), Ca-Mi (Italy), FeelLife Health (U.S), GF Health Products (U.S), Invacare (U.S), Medline Industries (U.S), PARI Medical Holding GmbH (Germany), OMRON (Japan), Phillips (Netherlands), Teleflex (U.S), Trudell Medical (Canada), among others.
The Global Nebulizer Market Has Been Segmented Into:
The Global Nebulizer Market – by Type:
- Jet
- Mesh
- Ultrasonic
The Global Nebulizer Market – by End-User Type:
- Home Healthcare
- Emergency Centers
- Hospitals and Clinics
The Global Nebulizer Market – by Regions:
- North America
- The U.S.
- Canada
- Mexico
- Europe
- U.K.
- France
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- India
- China
- Japan
- Australia
- Rest of Asia Pacific
- LAMEA
- Middle East
- Saudi Arabia
- UAE
- Others
- Latin America
- Brazil
- Chile
- Others
- Africa
- South Africa
- Egypt
- Others
Browse the full report at https://www.sheeranalyticsandinsights.com/market-report-research/nebulizer-market-21
No comments:
Post a Comment